Authorised Product Lines

Four instruments. One discipline.

Each product line is engineered to preserve principal, align HLC's interests with those of the claimant, and respect the absolute authority of counsel over litigation strategy. Returns are structured against duration-banded thresholds; commercial terms are documented on a single standard form, varied only by transaction-specific terms.

PRODUCT ILFA

Litigation Funding Agreement

Non-recourse capital for active claims.

Counterparty — Original claimant · represented

In Plain Terms

We pay your legal costs to pursue a serious claim. You repay only if you recover. There is no upfront fee.

HLC advances counsel fees, expert costs, court fees, and disbursements throughout the matter. Capital is deployed in tranches against an agreed budget. If the case fails, HLC absorbs the loss in full and the claimant owes nothing.

  • No upfront fee
  • Non-recourse — proceeds-only repayment
  • Tranched deployment against milestones
  • Return: greater of capital multiple or % of gross recovery

Proceeds Waterfall

  1. 01Adverse costs orders funded by HLC
  2. 02HLC capital repaid
  3. 03HLC return (greater of multiple or % of gross)
  4. 04Counsel contingency fee
  5. 05Balance — substantial majority — to claimant
PRODUCT IICPF

Claim Purchase Funding

Acquisition financing for qualified Purchasers.

Counterparty — Third-party investor / acquirer — not the original claimant

In Plain Terms

Capital provided to a qualified Purchaser to acquire a commercial claim from its current owner. The Purchaser then prosecutes the claim through a dedicated SPV with separately arranged litigation funding.

HLC takes a first-priority security interest in the acquired claim and all proceeds, recovering its capital plus a 2.0×–2.5× success multiple before any distribution to the Purchaser. Every transaction is preceded by a complete champerty and maintenance analysis.

  • 3–5% upfront origination fee, paid by Purchaser pre-deployment
  • First-priority security interest in claim and proceeds
  • 2.0×–2.5× success multiple to HLC before Purchaser distribution
  • Champerty and maintenance reviewed in every jurisdiction

If you are the original claimant seeking liquidity while retaining control of your matter, see Product III — Silent Partner.

PRODUCT IIISilent Partner

Direct Claim Acquisition

Liquidity today; control retained by claimant.

Counterparty — Original claimant · represented

In Plain Terms

HLC pays you an upfront Purchase Price for a defined economic interest in your claim. You keep full control of the litigation. Our involvement is not voluntarily disclosed to opposing parties.

HLC acquires an economic interest of up to 49% in the proceeds of the matter directly from the claimant. Strategy and counsel direction remain entirely with the claimant; HLC takes no consent rights over litigation conduct beyond standard institutional protections.

  • Up to 49% economic interest — claimant retains majority and control
  • 3–5% non-refundable Upfront Fee paid to HLC at closing
  • Confidential — HLC involvement not voluntarily disclosed
  • Return: greater of capital multiple or % of gross recovery
PRODUCT IVHLCDC

Counterclaim Funding

Hudson Litigation Defense Capital — separate affiliate.

Counterparty — Corporate defendant holding a meritorious affirmative counterclaim

In Plain Terms

If your client has been sued and holds a counterclaim with credible recovery, HLCDC funds the prosecution of the counterclaim on a fully non-recourse basis. HLCDC does not fund defense costs.

HLCDC is constituted as a separate legal entity with its own capital pool, Investment Committee, and compliance function. A strict information barrier separates HLCDC from HLC. Counterclaim value band: $5M–$50M. Probability ≥60% post-Optimism Discount; Enforcement Score ≥3.

  • No upfront fees
  • Funds counterclaim prosecution only — never defense costs
  • Non-recourse — counterclaim proceeds only
  • Tranched drawdown direct to counsel or approved vendors

Return Architecture

Duration-banded minimum thresholds.

Every commitment must clear the applicable floor under the base scenario. The IC's return is the greater of a multiple of deployed capital or a defined percentage of gross recovery. Both metrics are tested independently.

Expected Duration
Min Multiple
Min IRR
0–18 months
2.5×
≥45%
19–36 months
3.0×
≥40%
37–60 months
3.5×
≥35%
60+ months
4.0×
≥30%

These are minimum thresholds for IC consideration. Actual commercial terms are negotiated matter-by-matter and documented in the executed agreement.

Submit a matter for preliminary diligence.

Request Capital Review →